In addition to working with several Contract Research Organizations in the US, Europe and Asia, Acidophil has entered strategic innovation partnerships with Isomerase and New Path Molecular focused on applying their unique technologies to problems Acidophil is seeking to address in animal health.
Isomerase Therapeutics is a drug discovery and development company with extensive expertise in the discovery and development of optimised microbial natural products. They offer a proven route to develop these hits into drugs via their unique biosynthetic medicinal chemistry services.
New Path Molecular Research has a team of creative chemists supported by sophisticated machine assisted chemistry tools that specialise in the chemical synthesis of complex functional molecules. The molecules developed by New Path Molecular Research are used to validate biological processes and produce products globally.